Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 23501.71 | 1445 / 1445 | 100% | 137.38 | 183 / 183 |
pancreas | 100% | 17381.56 | 328 / 328 | 100% | 107.30 | 178 / 178 |
prostate | 100% | 13198.27 | 245 / 245 | 100% | 166.99 | 502 / 502 |
thymus | 100% | 14988.93 | 652 / 653 | 100% | 153.32 | 605 / 605 |
uterus | 100% | 8327.36 | 170 / 170 | 100% | 149.61 | 458 / 459 |
intestine | 100% | 14003.13 | 966 / 966 | 100% | 113.66 | 525 / 527 |
ovary | 100% | 8278.29 | 180 / 180 | 100% | 100.43 | 428 / 430 |
lung | 100% | 19622.60 | 577 / 578 | 100% | 127.17 | 1150 / 1155 |
stomach | 100% | 12312.55 | 359 / 359 | 99% | 109.32 | 284 / 286 |
breast | 100% | 14149.99 | 459 / 459 | 99% | 132.57 | 1110 / 1118 |
kidney | 100% | 8713.82 | 89 / 89 | 99% | 83.19 | 893 / 901 |
bladder | 100% | 12536.62 | 21 / 21 | 99% | 123.95 | 499 / 504 |
adrenal gland | 100% | 11866.23 | 258 / 258 | 98% | 83.59 | 226 / 230 |
skin | 99% | 16799.34 | 1797 / 1809 | 99% | 80.92 | 466 / 472 |
liver | 100% | 9865.04 | 225 / 226 | 98% | 65.09 | 399 / 406 |
brain | 67% | 4902.88 | 1771 / 2642 | 98% | 45.97 | 690 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 231.39 | 29 / 29 |
muscle | 100% | 127389.47 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 18725.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 233.87 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 56.36 | 1 / 1 |
adipose | 100% | 14886.44 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 9894.90 | 1324 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 72.04 | 79 / 80 |
peripheral blood | 99% | 28266.84 | 916 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 9608.21 | 832 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0030097 | Biological process | hemopoiesis |
GO_0006417 | Biological process | regulation of translation |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0097192 | Biological process | extrinsic apoptotic signaling pathway in absence of ligand |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0071243 | Biological process | cellular response to arsenic-containing substance |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0016605 | Cellular component | PML body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0009931 | Molecular function | calcium-dependent protein serine/threonine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004683 | Molecular function | calmodulin-dependent protein kinase activity |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MKNK2 |
Protein name | non-specific serine/threonine protein kinase (EC 2.7.11.1) MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2) MAPK interacting serine/threonine kinase 2 |
Synonyms | GPRK7 MNK2 |
Description | FUNCTION: Serine/threonine-protein kinase that phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. May play a role in the response to environmental stress and cytokines. Appears to regulate translation by phosphorylating EIF4E, thus increasing the affinity of this protein for the 7-methylguanosine-containing mRNA cap. Required for mediating PP2A-inhibition-induced EIF4E phosphorylation. Triggers EIF4E shuttling from cytoplasm to nucleus. Isoform 1 displays a high basal kinase activity, but isoform 2 exhibits a very low kinase activity. Acts as a mediator of the suppressive effects of IFNgamma on hematopoiesis. Negative regulator for signals that control generation of arsenic trioxide As(2)O(3)-dependent apoptosis and anti-leukemic responses. Involved in anti-apoptotic signaling in response to serum withdrawal. . |
Accessions | Q9NV89 K7ELN0 ENST00000309340.11 [Q9HBH9-2] ENST00000591588.1 K7EJ98 ENST00000250896.9 [Q9HBH9-1] K7ELG3 K7EK27 ENST00000588014.5 K7EMP5 ENST00000589534.2 ENST00000589441.5 ENST00000591142.5 ENST00000589509.5 ENST00000586828.5 K7EIN7 Q9HBH9 |